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The Silent Information Regulator-2 gene (Sir2) encodes 
an NAD-dependent histone deacetylase that links regu-
lation of chromatin, genomic stability, and life span in 




































































































inhibits transcription at several genetic loci and represses 
recombination at ribosomal DNA (rDNA) repeats [1-3].  
Yeast with mutations in Sir2 have increased genomic 
instability in the context of rDNA recombination, which 
in turn shortens replicative life span – a marker of 
reproductive aging in this organism [4]. Conversely, extra 
 
   
www.impactaging.com                  109                                 AGING, January 2009, Vol.1 No.1copies of Sir2 that suppress rDNA recombination 
increase replicative life span [4].  These effects of Sir2 
suggest paradigms in which genes that promote genome 
stabilization through chromatin modulation may be 
important contributors to regulation of organismal life 
span, aging, and age-related pathology.  
 
Consistent with a conserved role for Sir2 factors in life 
span regulation, increased activity of Sir2 proteins in 
the multi-cellular organisms C. elegans and D. 
melanogaster also increases life span [5, 6].  However, 
these Sir2 factors may operate through mechanisms that 
are independent of genome stabilization, and their 
physiologic molecular substrates are still unclear.  In 
mammals, there are seven Sir2 family members, SIRT1-
SIRT7 [7, 8].  The SIRTs have been of great interest as 
candidate regulators of mammalian life span and aging-
related processes.  In this context, several mammalian 
SIRTs have functions that impact on aging-associated 
molecular pathways and disease [9, 10].  However, 
initial studies of mammalian SIRTs linked these 
enzymes to biochemical targets and cellular functions 
that are distinct from those of S. cerevisiae Sir2.  For 
example, mammalian SIRT1 was first reported to 
deacetylate the p53 tumor suppressor protein [11, 12]; 
only later was SIRT1 shown to have a physiologic role 
in histone deacetylation, chromatin regulation, and most 
recently, genome stabilization [13, 14].  Other mamma-
lian SIRTs (SIRT2-SIRT5) are reported to have 
cytoplasmic or mitochondrial substrates (though recent 
work suggests that sub-cellular shuttling might allow 
these enzymes to target histones as well) [9, 10].  In 
addition, several studies had not detected histone 
deacetylase activity for the other nuclear SIRT proteins, 
SIRT6 and SIRT7 [15, 16].  Thus, until recently, the 
extent to which the functional link of yeast Sir2 to 
chromatin and genome maintenance is evolutionarily 
conserved in mammals has been unclear.  
 
The generation of mice deficient for the mammalian 
SIRT6 gene revealed a potential role for SIRT6 in 
linking regulation of life span, chromatin, and genomic 
stability [17].  In this context, SIRT6 deficiency in mice 
leads to dramatically shortened life span and acute 
degenerative phenotypes that overlap with pathologies 
of premature aging.  Moreover, SIRT6 knockout mouse 
cells have genomic instability and DNA damage 
hypersensitivity.  In biochemical fractionation assays, 
SIRT6 protein associates preferentially with a 
chromatin-enriched cellular fraction [17].  Together, 
these observations suggested that SIRT6 might couple 
chromatin regulation with DNA repair.  However, a 
physiologic role for SIRT6 in such a process has not yet 
been demonstrated.  
 
We recently discovered a molecular function for SIRT6 
at chromatin.  We showed that SIRT6 deacetylates a 
specific histone residue, lysine 9 of histone H3 (H3K9), 
in the context of chromatin at telomeres [18].  SIRT6 
thereby stabilizes the association with telomeres of the 
protein WRN, a DNA metabolic factor that is mutated 
in the human progeria Werner Syndrome.  In this 
context, depletion of SIRT6 in human cells leads to 
telomere dysfunction and genomic instability with end-
to-end chromosomal fusions.  We also identified a 
second physiologic context for SIRT6 function as a 
histone H3K9 deacetylase [19].  Specifically, SIRT6 is 
recruited to the promoters of genes that have been 
activated by the NF-κB transcription factor, 
deacetylates H3K9 at these promoters to attenuate gene 
expression, and thereby limits NF-κB signaling.   
Notably, hyperactive NF-κB signaling contributes 
significantly to the degenerative phenotypes and early 
death of SIRT6-deficient mice, because in an NF-κB-
haploinsufficient genetic background, SIRT6-deficient 
mice have milder phenotypes and live much longer than 
mice with SIRT6-deficiency alone [19]. Thus, 
chromatin regulation by SIRT6 is important for proper 
telomere function and regulation of gene expression 
programs, and both these mechanisms of action may 
impact on genomic stability and aging.   
 
Here, we report findings that further expand the known 
functions of SIRT6 and show that SIRT6 is required for 
efficient DNA DSB repair in the context of chromatin.  
Biochemical analyses show that SIRT6 associates 
dynamically with chromatin in response to DNA 
damage, and stabilizes the DNA DSB repair factor, 
DNA-dependent protein kinase (DNA-PK), at DSBs.   
We suggest that the modulation of DSB repair by 
SIRT6 in response to chronic DNA damage over life 
may contribute to the effects of SIRT6 on physiologic 




SIRT6 interacts with the DNA DSB repair factor 
DNA-PK  
 
To identify new molecular pathways of SIRT6 function, 
we employed a biochemical approach to identify 
SIRT6-interacting factors.  HeLa cell nuclear extracts 
were size-fractionated by gel filtration, and the presence 
of SIRT6 in individual fractions assessed by Western 
analysis.  Rather than fractionating at the expected size 
of a SIRT6 molecule (~40 KD), SIRT6 was detected in 
multiple peaks corresponding to large protein 
complexes ranging up to ~700 KD (Figure 1a).  These 
data  suggested  that  SIRT6  is a component of multiple  
 
   










































large macromolecular complexes.  To purify such 
complexes and identify their components, we expressed 
epitope (Flag)-tagged SIRT6 protein in 293T cells,  and  
carried out affinity-purification of Flag-SIRT6 com-
























































tes (IPs) revealed several protein bands specific to the 
IP from the Flag-SIRT6-expressing cells compared to 
negative control cells (Figure 1b).   SIRT6-specific 
bands were excised, and subjected to mass spectrometry.  
This analysis identified DNA-PKcs, Ku80, and Ku70, 
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central regulator of DNA DSB repair in mammalian 
cells (Figure 1b) [20-22].   
 
The interaction of SIRT6 with DNA-PKcs, Ku80, and 
Ku70 was confirmed by Western analysis of the Flag-
SIRT6 and negative control IPs (Figure 1c, d).  Notably, 
the interaction of SIRT6 with DNA-PKcs was resistant 
to ethidium bromide (Figure 1d), which disrupts DNA- 
dependent interactions.  In contrast, the association of 
Ku70 and Ku80 with SIRT6 was DNA-dependent 
(Figure 1d), similar to their interaction with DNA-PKcs 
[23, 24].  These data suggest that SIRT6 interacts with 
the DNA-PK holoenzyme complex via the DNA-PKcs 
catalytic subunit.  Thus, we focused our analysis on the 
SIRT6-DNA-PKcs interaction. Using SIRT6-specific 
antibodies, we immunoprecipitated endogenous SIRT6 
protein from 293T cells, and DNA-PKcs was 
specifically detected in these IPs (Figure 1e). Thus, our 
data indicate that SIRT6 and DNA-PKcs interact 
physically under physiologic conditions in cells.  
  
Mobilization of SIRT6 to chromatin in response to 
DNA damage 
 
In addition to the DNA-PK proteins, the purified SIRT6 
complex also contained four low molecular weight 
bands with migration patterns characteristic of the core 
nucleosomal histones (Figure 1b). Western analysis of 
several different Flag-SIRT IPs confirmed that histones 
H2A, H2B, H3, and H4 are specifically associated with 
Flag-SIRT6 (data not shown). The observation that 
levels of the four core histones are similar in the SIRT6 
IP (Figure 1b) suggested that the SIRT6-histone 
interactions could occur in the structural context of 
intact nucleosome particles. To investigate this possibi-
lity, we analyzed binding of purified, recombinant 
SIRT6 protein to purified mononucleosomes using an in 
vitro nucleosome binding assay.  SIRT6 protein bound 
efficiently to mononucleosomes, as manifested by a 
significant shift of the nucleosomes when fractionated 
on a non-denaturing gel; for comparison, SIRT1 did not 
show significant nucleosome binding in this assay 
(Figure 2a).  Together, these data provide evidence for a 
direct SIRT6 interaction with nucleosomes, the basic 
unit of chromatin. 
 
The observation that SIRT6 interacts with a core DSB 
repair factor and with nucleosomes suggested that 
SIRT6 might modulate DNA DSB repair in the context 
of chromatin.  To investigate this possibility, we first 
asked whether the association of SIRT6 with chromatin 
might be dynamic and modulated by DNA damage. 
Previously, biochemical fractionation experiments 
showed that a majority of SIRT6 protein in cells is detec- 
ted in an insoluble nuclear fraction enriched for 
chromatin [17].  To make it possible to detect potential 
changes in the strength of the SIRT6 interaction with 
chromatin, we used a more stringent chromatin 
fractionation protocol, under which, in the absence of 
DNA damage, only a minor portion of SIRT6 is 
associated with the purified chromatin fraction (Figure 
2b, c) [25].  Upon exposure of cells to DNA damage, 
using the radiomimetic DNA DSB agent 
neocarzinostatin (NCS), this assay revealed a dramatic 
shift of SIRT6 protein into the chromatin-bound 
fraction (Figure 2c).  We conclude that DNA damage 
triggers increased association of SIRT6 with chromatin 
under physiologic conditions in cells. 
 
SIRT6-deficient cells show global hyperacetylation 
of H3K9 in response to DNA damage 
 
Because SIRT6 is a histone deacetylase with specificity 
for H3K9, we next asked whether alterations in cellular 
levels of SIRT6 protein might influence H3K9 
acetylation (H3K9Ac) under DNA damage conditions. 
Therefore, we stably knocked down SIRT6 expression 
in cells by retroviral transduction of SIRT6-specific 
short-hairpin RNAs (shRNA) or negative control vector 
(pSR).  Two independent SIRT6 shRNAs (S6KD1 and 
S6KD2) resulted in significant knock-down (KD) of 
SIRT6 expression in multiple cell lines, as previously 
described (Figure 3a) [18].  We then confirmed that 
SIRT6 KD cells are hypersensitive to DNA damage 
(Figure 3b), demonstrating that the knockdown 
efficiency is sufficient to elicit known effects of SIRT6 
inactivation [17].  Next, Western analysis was 
performed to compare levels of global H3K9 
acetylation in SIRT6 KD or control pSR cells, under 
base-line conditions, or upon exposure to DNA DSB 
agents.  No difference in global H3K9Ac levels was 
observed in the absence of DNA damage (Figure 3c), 
consistent with our previous results [18].  However, 
when cells were treated with NCS or another DSB 
agent, bleomycin, H3K9Ac was substantially higher in 
SIRT6 KD cells compared to pSR cells (Figure 3c).   
Interestingly, this effect corresponded to a DNA 
damage-dependent decrease in H3K9Ac in pSR cells, 
rather than a damage-dependent increase in H3K9Ac in 
the S6KD cells.  We also examined effects on H3K9Ac 
of over-expressing SIRT6 in the context of DNA 
damage.  SIRT6 over-expression led to a greater 
reduction in H3K9Ac levels than NCS treatment, and 
addition of NCS did not further decrease global 
H3K9Ac levels (Figure 3d).  Together, our observations 
suggest that H3K9 is acutely deacetylated following 
treatment of cells with DNA damage, and SIRT6 is 
required for this process. 
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SIRT6 is required for efficient mobilization of DNA-
PKcs to chromatin following DNA damage 
 
Previous studies showed that exposure of cells to DNA 
DSB agents leads to mobilization of DNA-PKcs to 
chromatin [25].  To test whether SIRT6 might function 
in this context, the levels of chromatin-associated DNA-
PKcs following exposure of SIRT6 KD and control 
cells to NCS were compared.  Consistent with previous 
studies [25], in the SIRT6-proficient pSR cells, DNA 
DSB generation was accompanied by an increase in the 
levels of DNA-PKcs at chromatin (Figure 4a, compare 
lane 6 to lane 3).  In contrast, no change in DNA-PKcs 
levels at chromatin was observed in SIRT6 KD cells in 
response to DNA damage (Figure 4a, lanes 9 and 12).  
Similar results were observed in SIRT6 KD cells 
generated with the other SIRT6 shRNA (Figure 4b); 
thus, the changes in DNA-PKcs mobilization cannot be 
attributed to off-target shRNA effects.  Moreover, 
reconstitution of SIRT6 KD cells with wild-type SIRT6 
protein (S6WT) restored DNA damage-dependent 
mobilization of DNA-PKcs to chromatin, whereas 
reconstitution with a catalytically inactive SIRT6 
(S6HY) mutant protein did not (Figure 4c, d).  We 
conclude that functional SIRT6 protein is required for 
efficient stabilization of DNA-PKcs at chromatin in 
response to DNA damage. 
  
Dynamic association of SIRT6 and DNA-PKcs with 
chromatin flanking DNA DSBs  
 
To study the dynamic movements of both SIRT6 and 
DNA-PK in the context of chromosomal DNA DSBs, 
we set up a recently described system to monitor 
molecular events that occur at chromatin adjacent to 
defined, endogenous DNA DSB target sites in human 
cells [26].  This system makes use of the eukaryotic 
homing endonuclease I-PpoI, which has ~300 target 
sites in the human genome [26].  To generate DSBs at 
these sites, we transduced human cell lines with a retro-
viral cassette containing an inducible system to express 
I-PpoI enzyme.  Chromatin immunoprecipitation (ChIP) 
was then performed with SIRT6-specific antibodies, 
and the presence of chromatin near (182 bp) a specific 
DSB was determined by quantitative real-time PCR.   
This analysis revealed that I-PpoI expression leads to a 
~4-fold increase in mobilization of SIRT6 protein to 
chromatin adjacent to the DSB site (Figure 5a).  This 
increase in signal was abrogated in SIRT6 KD cells, 
confirming the specificity of the assay. 
 
Next, we asked whether SIRT6 influences the 
recruitment of DNA-PKcs to the chromosomal DSBs.  
Similar to SIRT6, DNA-PKcs was significantly 
increased (>5-fold) at sequences adjacent to the DSB 
following I-PpoI expression (Figure 5b).  Notably, 
depletion of SIRT6 in the SIRT6 KD cells dramatically 
reduced the mobilization of DNA-PKcs to the DSBs.   
These results were confirmed with an independent site-
specific break system, using the I-SceI endonuclease 
(Figure 5c) [27, 28].  I-SceI has no endogenous target 
sites in human cells; therefore, we generated cells 
harboring stably integrated I-SceI target sites by 
retroviral transduction, and then expressed the I-SceI 
enzyme.  DNA DSB induction by I-SceI led to a ~5-fold 
increase in DNA-PKcs levels at sequences close to 
(~60-200 bp) the I-SceI target sequence, but not farther 
away (~1600-1670 bp) from the DSB (Figure 5c).   
Again, this recruitment of DNA-PKcs was not observed 
in SIRT6 KD cells.  
 
To determine whether increasing SIRT6 levels can 
further drive DNA-PKcs to DSBs, we also carried out 
the site-specific DSB analysis following retroviral over-
expression of wild-type or catalytically inactive SIRT6 
protein (Figure 5d). Over-expression of wild-type 
SIRT6 further increased DNA-PKcs at the DSB by ~3 
fold.  In contrast, the mutant SIRT6-HY protein reduced 
the DNA-PKcs signal, suggesting a possible dominant-
negative effect.  Together, our results demonstrate that 
SIRT6 is necessary and sufficient to promote efficient 
recruitment of DNA-PKcs to chromatin flanking site-
specific DSBs. 
 
SIRT6 is required for efficient DNA DSB repair 
 
The above observations suggested that SIRT6 might 
influence the efficiency of DNA DSB repair.  To test 
this possibility, we used comet assays to compare levels 
of DNA damage in single-cells, at base-line conditions 
or upon exposure to DSB agents (Figure 6a). In this 
assay, cells were embedded in agarose plugs, and 
subjected to electrophoresis.  Intact genomic DNA 
shows very poor mobility under these conditions; DNA 
DSBs increase the migration of the DNA, generating 
“comets” of DNA detected by SYBR Green staining 
(Figure 6b).  The relative size of the comet “tail 
moment” was used to assess levels of DSBs in 
individual cells, and these values were plotted on a 
histogram for >100 cells (Figure 6a).  In the absence of 
NCS, the distribution of tail moments for SIRT6 KD 
and control cells were similar (Figure 6a, top).  In both 
cell types, NCS treatment led to a shift in tail moment 
distribution, with more cells showing larger amounts of 
DNA damage (Figure 6a, bottom).  However, this NCS-
dependent increase in tail moment distribution was 
significantly greater for SIRT6 KD cells compared to 
control pSR cells.  This difference is reflected in an 
increased population Mean Tail Moment in NCS-treated 
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vide evidence that SIRT6 KD leads to impaired 
resolution of DNA DSBs and increased accumulation of 
broken DNA.  
 
To validate that the impaired chromatin mobilization of 
DNA-PKcs and increased DNA breaks observed in 
SIRT6 KD cells is specific to depletion of SIRT6, and 
to determine the role of SIRT6 enzymatic activity in 
this process, we used the S6KD cells reconstituted with 
the wild-type or catalytically inactive SIRT6 proteins 
(Figure 4c).  Complementation with wild-type SIRT6 
protein in SIRT6 KD cells reduced the levels of NCS-
dependent DSBs to levels observed in control cells 
(Figure 6d).  In contrast, the mutant SIRT6 protein was 
impaired in its ability to reverse the DNA DSB 







































Finally, to assay the effect of SIRT6 on DNA DSB repair 
by an independent method, we used the I-PpoI and I-SceI 
site-specific DSB systems.  Following DSB induction by 
expression of each endonuclease, PCR amplification of 
DNA was carried out using primers flanking the break 
sites.  Comparison of the levels of PCR products was 
then used to quantify the relative efficiency with which 
the DSBs are resolved in SIRT6 KD or control cells.  In 
these assays, SIRT6 KD led to a ~4-fold decrease in the 
fraction of intact DNA present when assayed following I-
SceI expression, and an even greater decrease using the I-
PpoI system (Figure 6e). In contrast, SIRT6 depletion 
from nuclear extracts (Figure 7a) had no effect on DSB 
repair in an in vitro cell-free assay, in which the DNA is 
free and not bound within chromatin (Figure 7b).  Thus, 
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these observations support a model in which SIRT6 
impacts on DNA repair by modulating the association of 




Previous work suggested that SIRT6 contributes in some 
way to DNA repair, because SIRT6-deficient mouse cells 
are hypersensitive to DNA damage and show increased 
genomic instability [17]; however, until now, direct 
evidence for SIRT6 function in DNA repair pathways has 
not been described.  In this study, we have now linked 
SIRT6 to DNA DSB repair, and show that SIRT6 
modulates the levels of the DNA-PKcs DSB repair factor 
at chromatin surrounding DNA breaks.  It is possible that 
SIRT6 may also influence the chromatin association of 
other DNA repair factors.  For example, the spectrum of 
DNA damage agents to which SIRT6-deficient mouse 
cells are sensitive suggested a role for SIRT6 in Base 
Excision Repair (BER).  Thus, it will be interesting to 
investigate whether association of BER factors with 
chromatin at damaged DNA is regulated by SIRT6.  
 






























because previous results in SIRT6-deficient mice did 
not detect overt defects in Non-homologous End-joining 
(NHEJ), the specific DNA DSB repair pathway in 
which DNA-PK functions [17]. For example, SIRT6-
deficient mice have normal lymphocyte development 
and V(D)J recombination, a process of programmed 
DNA recombination of immunoglobulin genes that 
depends on NHEJ activity [29].  We suggest that in the 
context of V(D)J recombination, the requirement for 
SIRT6 may be overridden by the action of lymphocyte-
specific recombination factors, such as the RAG 
proteins, which are present at the sites of DSBs at 
V(D)J recombination substrates [21, 29].  Repair of 
chromosomal DNA DSBs also appeared grossly normal 
in SIRT6-deficient mouse cells; it is possible that the 
assays for DNA DSBs used in our new study (comet 
assays for DNA damage in single cells and site-specific 
DSB repair assays) provide better sensitivity than the 
previously used assay (pulsed field gel electrophoresis) 
[17].  It is also possible that differences between the 
mouse study and our new findings in human cells may 
be due to compensatory mechanisms in the mouse 
knockouts.  Regardless, our study highlights the 
usefulness of complementing genetic studies in mice 































Figure  5.  Dynamic  association  of
SIRT6 and DNA‐PKcs with chroma‐
tin flanking site‐specific DNA DSBs.
(A)  SIRT6  occupancy  at  chromatin
flanking  DSBs  induced  by  I‐PpoI.
Quantitative  real‐time  PCR  amplifica‐
tion of DNA sequences flanking the I‐
PpoI  site  from  ChIPs  performed  with
SIRT6 antibodies.  Data are normalized
to  no  I‐PpoI  (control)  samples.  (B)
DNA‐PKcs  occupancy  at  chromatin
flanking  DSBs  induced  by  I‐PpoI,
determined  as  for  SIRT6  in  (A).  (C)
DNA‐PKcs  occupancy  at  the  indicated
distances  from  an  I‐SceI  DSB  site  in
SIRT6 KD and controls cells.  Data are
normalized  to  no  I‐SceI  controls.  (D)
DNA‐PKcs  occupancy  at  chromatin
adjacent to (+60 to +223 bp) an I‐SceI
DSB  site,  following  retroviral  over‐
expression  of  Flag‐tagged  wild‐type
SIRT6  (S6WT),  catalytically  inactive
SIRT6  (S6HY),  or  empty  vector  control
(pBabe).  In  all  panels,  SIRT6  KD  cells
were generated with S6KD2 shRNA, and
the data represent the mean +/‐ S.E. 
   












































Regarding the molecular mechanism of SIRT6 action in 
response to DNA damage, our findings, that SIRT6 is 
required for stabilization of DNA-PKcs association with 
chromatin at DSBs and for global deacetylation of 
H3K9 upon DNA damage, are consistent with several 
potential models. For example, SIRT6 could be targeted 
to DSBs first and then recruit DNA-PKcs; DNA-PKcs 
could bind DSBs first and then recruit SIRT6; or the 
two proteins might associate with chromatin at DSBs 
cooperatively as a result of their protein-protein 






















































specific DSBs suggests a model in which it deacetylates 
H3K9 at chromatin surrounding the DSBs.  However, 
we were unable to detect reproducible effects of SIRT6 
on H3K9Ac at DSBs using the site-specific DSB 
systems.  One possibility is that there is a tightly 
regulated acetylation/deacetylation cycle of H3K9 that 
occurs acutely in response to DNA damage, and effects 
of SIRT6 on this process could be beyond the resolution 
of our current assays.  SIRT6 might also impact on 
DNA damage-dependent H3K9Ac levels indirectly, for 
example, by altering the kinetics of cell-cycle dependent  
   



























histone acetylation fluctuations or through an as-yet 
undefined substrate.  Future studies of SIRT6 biology in 
these contexts should allow us to distinguish among 




In eukaryotic cells, genomic DNA is packaged in the 
higher order structure of chromatin, and regulation of 
chromatin plays a fundamental role in diverse 
epigenetic programs [30].  Such programs, in turn, can 
impact on aging-related molecular processes [31].  In 
this context, mammalian SIRT proteins that regulate 
histone deacetylation at chromatin can contribute to 
aging and life span regulation.  We recently showed that 
SIRT6 regulates both telomere function and aging-
associated gene expression programs via site-specific 
deacetylation of H3K9 at chromatin, and loss of these 






































ture senescence of human cells or a degenerative 
phenotype reminiscent of premature aging in mice [18, 
19].  Increasing evidence suggests that chromatin 
dynamics also play critical roles in the surveillance, 
detection, and repair of DNA damage [32, 33].  The 
human genome is continually exposed to environmental 
and metabolic sources of DNA damage, the 
accumulation of which is proposed to contribute to 
genomic instability, aging, and age-related pathologies 
[31, 34-36].  Thus, chromatin regulatory factors that 
function in this context may be important aging 
modulators.  Recent work by Oberdoerffer et al showed 
that SIRT1 promotes repair of DSBs, and proposed that 
SIRT1 provides an example of how DNA damage-
dependent redistribution of a chromatin modifying 
factor (the “RCM” response) may contribute to 
epigenetic changes that influence aging phenotypes 
[14].  Our findings regarding SIRT6 provide a second 
example  of  a  mammalian  SIRT  functioning  in  DNA  
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SIRT factors in linking chromatin regulation, DNA 




Antibodies and constructs. SIRT6 antibodies were 
previously described [16].  Commercial antibodies: H3, 
H4, and Ku70 (Abcam); H2A, H2B, SIRT1, and a-
Tubulin (Upstate); Flag (Sigma); GST, Ku80, and 
DNA-PKcs (Santa Cruz Biotechnology); DNA-PKcs 
(Neomarkers).  The Flag-tagged human SIRT1 
expression construct was generated by sub-cloning into 
the p3xFlag vector (Sigma). Flag-tagged SIRT 
expression constructs in pcDNA were previously 
described [15]. Flag-SIRT6 wild-type and HY mutant 
retroviral expression constructs were generated by 
subcloning into the pBabe-puro vector. 
 
Gel Filtration. HeLa cell nuclear extract was prepared as 
described previously [37].  3.5 mg of HeLa cell nuclear 
extract was loaded onto a 24-ml Superose 6 column 
(GE Healthcare) pre-equilibrated with 250 mM NaCl, 
0.1% Triton X-100, 150 mM Tris pH 7.4, 10% glycerol 
buffer, run in the same buffer at a flow rate of 0.5 
ml/minute.  72 fractions of 0.5 ml were collected and 
analyzed for the presence of SIRT6 by western blot.   
Molecular weight standards (GE Healthcare) were used 
to calibrate the column as indicated. 
 
Immunoprecipitation and purification of Flag-SIRT6 
Complexes. 293T cells were transiently transfected 
using the TransIT-293 (Mirus) transfection reagent 
according to the manufacturer’s instructions.  Cells 
were lysed 48 hrs post-transfection in IP-lysis buffer (50 
mM Tris-HCl [pH 7.4], 250 mM NaCl, 0.25% Triton X-
100, 10% glycerol, and complete protease inhibitor 
cocktail (Roche)).  The cell extracts were immuno-
precipitated with anti-Flag M2 monoclonal antibody-
conjugated agarose beads (Sigma).  Immunocomplexes 
were eluted with 3xFlag peptide (Sigma) and resolved 
by SDS-PAGE.  Proteins were analyzed by Western 
blot or Coomassie stained with Gelcode reagent (Pierce) 
and SIRT6-specific bands excised for analysis by mass 
spectrometry.  Where indicated, lysates were first 
incubated on ice for 30 minutes with 50 µg/ml ethidium 
bromide.   
 
Nucleosome-binding assays. Mononucleosomes were 
purified from HeLa cells as described [38].  1.5 μg 
mononucleosomes were incubated with or without 10 
μg of recombinant SIRT1 or SIRT6 protein for 30 
minutes at 30°C in histone binding buffer (20 mM 
HEPES pH 7.9, 80 mM KCl, 0.1 mM ZnCl2, 0.1% 
EDTA, 10% glycerol, 0.1% NP40, 0.5 mM DTT, 1 mM 
PMSF) in a total volume of 20 μl.  Reactions were 
fractionated on a 5% non-denaturing TBE gel, and 
mononucleosomal DNA stained with ethidium bromide.  
 
Chromatin purification and cell fractionation. Cellular 
fractionation was performed as previously described 
[25].  Briefly, 1x106 HeLa cells were incubated  ± 760 
ng/ml neocarzinostatin (NCS, Sigma) for 1 hour at 
37°C, and washed and harvested in PBS.  The cell pellet 
was resuspended in 200 µl buffer 1 (150 mM NaCl, 50 
mM Hepes 7.5, 1 mM EDTA, 0.1% Triton X-100, 
protease inhibitor cocktail (Roche) and phosphatase 
inhibitor cocktail (Sigma)) for 3 minutes on ice.   
Lysates were pelleted at 13,000 rpm for 3 minutes, and 
the detergent extractable (Dt) supernatant collected.   
The insoluble pellet was washed 2X in Buffer 1 without 
Triton X-100, resuspended in 100 µl Buffer 2 (150 mM 
NaCl, 50 mM Hepes 7.5, 1 mM EDTA, 200 µg/ml 
RNaseA, protease inhibitor cocktail (Roche) and 
phosphatase inhibitor cocktail (Sigma)), and incubated 
at 25°C for 30 minutes with gentle agitation.  Samples 
were centrifuged at 13,000 rpm for 3 minutes, and the 
RNase extractable (Rn) supernatant collected.  The 
remaining pellet (Rnase-resistant, purified chromatin 
sample (Chr)) was resuspended in SDS loading buffer, 
boiled, and sonicated for solubilization prior to Western 
analysis.  
 
Generation of stable SIRT6 knock-down and 
reconstituted cell lines. SIRT6 knock-down cells 
(S6KD1 and S6KD2) were generated by retroviral 
transduction of shRNAs (target sequences: S6KD1, 5'- 
AAG CTG GAG CCC AAG GAG GAA-3'; S6KD2, 5'- 
AAG AAT GTG CCA AGT GTA AGA-3') in 
pSUPERretro (pSR), as previously described [18].  For 
reconstitution, S6WT and S6HY retroviruses were 
generated with pFBneo retroviral constructs as 
previously described [16]. 
 
DNA DSB and DNA damage sensitivity assays.  IR 
sensitivity assays of SIRT6 KD and control WI-38 cells 
were performed using colony formation assays as 
previously described [17].  For detection of DSBs, 
SIRT6 KD and control HeLa cells were treated ±NCS 
(250 ng/ml, 30 minutes), and Comet assays performed 
according to the manufacturer’s instructions (Trevigen).  
Levels of DSBs, assessed via quantification of tail 
moments, were determined by CometScore software.   
Approximately 100–125 cells were scored for each 
independent experiment. 
 
Cell-free DNA DSB repair assay.  150 ng of purified  
pUC19/HindII DNA fragments were incubated with 25 
µg or 50 µg of SIRT6- or mock- depleted nuclear 
extracts for 1 hour at room temperature, proteins 
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agarose gel.  DNA species were visualized by ethidium 
bromide staining. 
 
Mass Spectrometry. Gel slices were handled with a 
standard in-gel digest protocol (http://donatello.ucsf.edu/ 
ingel.html).  LCMSMS was run on a quadruple TOF 
instrument (QSTAR).  Protein identification database 
search was carried out with MASCOT.  
 
Site-specific DSB repair systems.  The I-PpoI assays 
were performed as previously described [26].  Control 
and S6KD HT1080 cells were infected with the HA-
ER-I-PpoI retrovirus for 24hrs.  The virus was removed 
and the cells were serum-starved for 36 hours in 
DMEM supplemented with 0.1% FBS for 
synchronization in G1.  The I-PpoI enzyme was then 
induced by the addition of 1uM 4-OHT (Sigma, St 
Louis, MO) for 24 hours.  The cells were harvested and 
genomic DNA from each sample was prepared using 
the Sigma GenElute mammalian genomic DNA mini-
prep kit.  To analyze double strand break generation and 
repair, purified DNA was quantified and 50ug of DNA 
from each sample was used for Real-time PCR using 
primers that flank the I-Ppo1 site at chromosome 1 (5’-
TCACTGAAGACTTGGTGGGA-3’, 5’-AAACCATAC 
GTGGCAGAGTG-3’) and GAPDH (5’-GCTTGCCCT 
GTCCAGTTAAT3-’, 5’-TAGCTCAGCTGCACCCTT 
TA3-’) as a control.  For the I-SceI system, to generate 
HT1080 cells stably encoding the I-SceI target sequence 
(5’-ATTACCCTGTTATCCCTA-3’) within a known 
sequence context (GFP cDNA), the I-SceI sequences 
were introduced into the MSCV retroviral transduction 
vector encoding GFP cDNA, and stably intergrated into 
the host genomic DNA by retroviral transduction.  To 
generate DSBs, I-SceI enzyme was expressed by 
transient transfection.  qRT-PCR primers for assaying 
intact DNA at the I-SceI target site are based on the 
known MSCV-GFP vector sequences flanking the I-
SceI sequence: (5’-ACATGGTCCTGCTGGAGTTC-
3’) and (5’-TAAAGCGCATGCTCCAGACT-3’). 
 
Chromatin Immunoprecipitation (ChIP) at site-specific 
DSBs.  ChIPs were performed as previously described 
[19].  Following endonuclease (I-SceI or PpoI) expres-
sion, DNA was cross-linked for 15 minutes with 1% 
formaldehyde and stopped in 0.125 M glycine.  Purified 
chromatin was sonicated to ~300 bp using the Bioruptor 
(Diagenode, Inc) and incubated with the indicated 
antibodies. Following reverse cross-linking, ChIP-
associated sequences were detected by quantitative 
Real-Time PCR.  PCR primers: I-SceI +60 to +223, (5'-
AGTCTGGAGCATGCGCTTTA-3') and (5'-GGGGAA 
CTTCCTGACTAGGG-3'); I-SceI +1614 to +1670, (5'-
CGCCTCAGCCAGCAACTC-3') and (5'-TAAGGCCG 
TTCTCTCGCATT-3'); I-PpoI, (5’-TTCACAGCACTC 
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